Search

Author/Creator Singavi, Arun

1. De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Issue 4 (18th March 2016)

Authors:
Alinari, Lapo; Gru, Alejandro; Quinion, Carl; Huang, Ying; Lozanski, Arletta; Lozanski, Gerard; Poston, Jacqueline; Venkataraman, Girish; Oak, Eunhye; Kreisel, Friederike; Park, Steven I.; Matthews, Stephanie; Abramson, Jeremy S.; Iris Lim, Hana; Martin, Peter; Cohen, Jonathon B.; Evens, Andrew; ...
Journal:
American journal of hematology
Issue:
Volume 91:Issue 4(2016:Apr.)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Issue 4 (June 2016)

Authors:
Alinari, Lapo; Gru, Alejandro; Quinion, Carl; Huang, Ying; Lozanski, Arletta; Lozanski, Gerard; Poston, Jacqueline; Venkataraman, Girish; Oak, Eunhye; Kreisel, Friederike; Park, Steven I.; Matthews, Stephanie; Abramson, Jeremy S.; Iris Lim, Hana; Martin, Peter; Cohen, Jonathon B.; Evens, Andrew; ...
Journal:
American journal of hematology
Issue:
Volume 91:Issue 4(2016:Apr.)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Issue 1 (24th January 2019)

Authors:
Conroy, Jeffrey M.; Pabla, Sarabjot; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Andreas, Jonathan; Giamo, Vincent; Wang, Yirong; Lenzo, Felicia L.; Bshara, Wiam; Khalil, Maya; Dy, Grace K.; Madden, Katherine G.; Shirai, Keisuke; Dragnev, Konstantin; Tafe, Laur...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Issue 1 (1st February 2019)

Authors:
Pabla, Sarabjot; Conroy, Jeffrey M.; Nesline, Mary K.; Glenn, Sean T.; Papanicolau-Sengos, Antonios; Burgher, Blake; Hagen, Jacob; Giamo, Vincent; Andreas, Jonathan; Lenzo, Felicia L.; Yirong, Wang; Dy, Grace K.; Yau, Edwin; Early, Amy; Chen, Hongbin; Bshara, Wiam; Madden, Katherine G.; Shirai, K...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rituximab, cyclophosphamide-fractionated, vincristine, doxorubicin and dexamethasone alternating with rituximab, methotrexate and cytarabine overcomes risk features associated with inferior outcomes in treatment of newly diagnosed, high-risk diffuse large B-cell lymphoma. Issue 12 (December 2013)

Authors:
Mato, Anthony; Feldman, Tatyana; Zielonka, Tania; Singavi, Arun; Gadaletta, Gabriella; Waksmundzki, Kathryn; Bhattacharyya, Pritish; Chow, Kar Fai; Yang, Xiao; Panush, David; Agress, Harry; Rosario, Maria; Howlett, Christina; Pecora, Andrew; Goy, Andre
Journal:
Leukemia & lymphoma
Issue:
Volume 54:Issue 12(2013:Dec.)
Page Start:
2606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗